Summary:
Phase I study for mild to moderate asthmatics. Medication is a combination of two medications delivered via IV.
Qualified Participants Must:
Be a healthy individual
Be 18-60 years of age
Have mild, stable asthma
Qualified Participants May Receive:
11 visits over a 100-day period (1 visit requires overnight stays), physical exams, breathing tests, lab tests, and compensation up to $1700.